Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.2B | 1.2B | 1.1B | 1.1B |
| Cost of revenue | 590.9M | 595.1M | 555.0M | 526.7M |
| Gross profit | 581.6M | 599.7M | 578.6M | 555.8M |
| Operating expense | ||||
| Research & development | 254.3M | 252.6M | 260.9M | 243.7M |
| Selling general and admin | 304.2M | 286.2M | 318.9M | 331.5M |
| Other operating expenses | — | — | — | — |
| Operating income | 23.1M | 13.7M | -1.2M | -19.3M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 3.5M | -27.2M | -2.5M | -6.9M |
| Pretax income | 26.6M | -13.6M | -3.7M | -26.2M |
| Tax provision | 6.6M | -1.1M | 6.1M | 5.6M |
| Net income | 20.0M | -12.5M | -9.7M | -31.9M |
| Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
| Basic average shares | 5.5B | 5.5B | 5.7B | 6.1B |
| Diluted average shares | 5.8B | 5.5B | 5.7B | 6.1B |
| EBITDA | 72.6M | 70.2M | 54.1M | 33.1M |
| Net income from continuing op. | 20.0M | -12.5M | -9.7M | -31.9M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |